Delivery Order SPE2DB25D3201-SPE2DB25FNSDX

Award Date 4/3/25
Potential Completion Date 4/24/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,963.20, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,908.00, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $16,372.10 with a firm fixed price for the supply of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has an ultimate completion date of March 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIALS, a medical product, with a ceiling value of $55,852.80 and a period of performance through April 29, 2025. This contract award is a delivery order against a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, valued at $11,801.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a medical product, with a period of performance through March 17, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award, valued at $3,606.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 1 GRAM/10 ML VIAL 10ML, a pharmaceutical product, and has an ultimate completion date of November 21, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $34,908.00, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML medical product. The award is a Firm Fixed Price Delivery Order with a performance period through February 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $51,945.36, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a critical medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award, valued at $3,662.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a medical product, to support federal healthcare programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $49,752.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 40 gram/400 ml vial, a pharmaceutical product, with a performance period through December 6, 2024. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNSDX
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,963.20, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a medical product, with an ultimate completion date of April 24, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/3/25, 2:44 PM